84
41
Growth Score 84 in past quarter
-3 pts
Heat Score 41 in past quarter
-18 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
3756131
Winston Therapeutics strives to be on the cutting edge of this evolution, driving the digital therapeutics and precision medicine solutions.
- Thomas Beck: Co-Founder and Co-CEO
- Wendy Popa: Co-Founder
About the Company
It’s time to rethink treatment for ADHD, dyslexia and related conditions. In a fast-paced, digital-first world, treatment must evolve to meet the needs of our modern society. Winston Therapeutics strives to be on the cutting edge of this evolution, driving the digital therapeutics and precision medicine solutions transforming the way we approach
these difficulties. Our divisions are focused on upending treatment barriers through technology.